Research and Forecast on China Insulin Market, (Sample)

Transcription

1 Research and Forecast on China Insulin Market, (Sample) Huidian Research Publication Date: April 2014

2 3. Trend of China Insulin Market in Current Situation Market Scale A survey conducted by Huidian Research shows that China s insulin market scale approximately registered CNY 11 billion in 2013, of which CNY 7.5 billion achieved in second-generation insulin market and CNY 3.5 billion generated in third-generation insulin market. Now third-generation insulin market grows faster than second-generation insulin. And second-generation insulin market will accelerate growing space because it is just listed into new essential drug catalogue. Fig. 9 Market Scale of China s Insulin, (Unit: CNY 100 million) Market Scale Y-o-Y Growth % 25.00% 20.00% 15.00% 10.00% 5.00% 0.00% Source: Huidian Research Table of Contents 1. Overview of Insulin 1.1 Brief Introduction to Diabetes & General Situation of Related Therapeutic Drugs Overview of Diabetes Clinical Classification of Diabetes Major Therapeutic Drugs, Clinical Effects and Treatment Strategy 1.2 Definition and Classification of Insulin Definition Classification 1.3 Development History of Insulin in China First-Generation Insulin (Multi-component Insulin Extracted from Animal Pancreas)

3 1.3.2 Second-Generation Insulin (Insulin Human) Third-Generation Insulin (Improved Insulin or Insulin Analogues) 2. Operation Environment of China Insulin Market in China s Economic Environment in Policy Environment in Opinions Concerning Deepening Medical and Health System Reform Planning and Implementation of Deepening Medical and Health System Reform During the 12 th Five-Year Plan Comprehensive Improved Standards for Insulin and Recombinant Human Insulin in Chinese Pharmacopoeia Educational Management Standards for Using Insulin Prevention Guideline of Type 2 Diabetes Mellitus in Continuous Anti-corruption in Medicine 2.3 Technological Environment in Insulin Pump Diabetes Treatment by Using Stem Cell Transplantation is on Clinical Test Stage 2.4 Chinese Consumers Cognition toward Insulin 3. Trend of China Insulin Market in Current Situation Development Status of Diabetes in China and at Overseas Market Scale 3.2 New Pattern of China Insulin Industry in Import and Export Data of Product Segments of Insulin in China, Import and Export Data of Insulin and Its Salt in China, (HS Code: ) 4.2 Export Data of Drugs Containing Insulin without Defined Daily Doses, (HS Code: ) 4.3 Import and Export Data of Drugs Containing Insulin with Defined Daily Doses, (HS Code: ) 5. Key Enterprises in Insulin Industry 5.1 Tonghua Dongbao Company Profile Business Performance Main Business Composition Progress of Research and Development Channel Expansion Development Plan in Wanbang Biopharmaceuticals Company Profile Business Performance

4 5.2.3 Third-Generation Insulin Approved to be used in Clinical Test Marketing Network Growth Pattern in the Next Five Years 5.3 United Laboratories Company Profile Business Performance Production Capacity New Products Marketing Promotion Channel Future Development Strategy 5.4 Gan & Lee Company Profile Business Performance Commercial Bribery Case Business Channel Expands to County-level Central Hospitals 5.5 Yabao Pharmaceutical Group Company Profile Channel Building Research & Development 5.6 Novo Nordisk Company Profile Business Performance Enterprise R&D 5.7 Eli Lilly and Company Company Profile Progress of R&D Overall Increase of Insulin Production Capacity in China Business Condition Channel Expansion 5.8 SANOFI Company Profile R&D Framework Enterprise Operation 6. Development Trend and Prospect Forecast of China Insulin Market, Development Prospect Enormous Insulin Market Potential Huge Oral Insulin Market Potential 6.2 Development Trend Opportunities and Challenges for Enterprise R&D brought by Policy Environment Change Development Trend of Insulin Products 6.3 China Insulin Market Forecast from 2014 to 2018

5